Tectonic Therapeutic, Inc. (TECX): Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand Tectonic Therapeutic, Inc. (TECX)

Tectonic Therapeutic, Inc. (TECX) management is implementing automated laboratories for 24/7 analysis of GPCR targets, which is reflected in the PEG ratio dynamics. Patent protection for biological modeling ensures steady demand for immune pathology therapies, while revenue is based on royalties from pharma behemoths. The current mark is 0.00, allowing for the timely identification of the asset's undervaluation relative to its growth rates.

TECX - Tectonic Therapeutic Inc. PEG Multiple over the range 06/22/2024 - 11/15/2026

Metric breakdowns and analytics for Tectonic Therapeutic Inc. (TECX)

Summary company analytics:Tectonic
Mass-produced product of Tectonic Therapeutic

The PEG ratio compares the P/E multiple to the rate of earnings expansion to determine whether the business growth dynamics justify the current share price. The 0.00 value on the growth-normalized P/E reflects the efficiency of the Tectonic Therapeutic, Inc. (TECX) outsourcing model, where the absence of manufacturing capital expenditures should translate into accelerated earnings growth to confirm the asset's fundamental stability.

Competing companies

HLN - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Kenvue Inc KVUE|Verona Pharma (VRNA) - Price to Earnings Adjusted for Growth Rate|MENS: Price/Earnings to Growth Multiple|Ligand - Company Value to Earnings Growth Ratio|AMRX: PEG Multiple|Perrigo Company - Growth-Adjusted Payback Ratio|ALVO (Alvotech S.A.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate liquidia.com LQDA|Price/Earnings to Growth Ratio Galapagos (GLPG)|ANIP (ANI Pharmaceuticals, Inc.) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Afrezza MNKD|PEG Multiple Amphastar Corp AMPH|Pacira Corp - PEG Multiple|Growth-Adjusted Payback Ratio SPRY (ars-pharma.com)|TBPH: PEG Multiple|Aquestive Therapeutics, Inc. (AQST) - PEG Multiple|SCPH (scpharmaceuticals.com) - PEG Multiple|Tonix Pharmaceuticals (TNXP) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SXTC|PEG Multiple Eupraxia Pharma (EPRX)|Price/Earnings to Growth Ratio BioHarvest Sciences Inc. BHST|EXOZ - Price/Earnings to Growth Multiple|ORMP: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate abvcpharma.com (ABVC)|Price/Earnings to Growth Ratio Cumberland Pharma|Price/Earnings to Growth Ratio QNTM|PEG Multiple FGEN|TELO (Telomir Pharma) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Rani Therapeutics Holdings RANI|SNYR - Price/Earnings to Growth Multiple|RLYB - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income lexariabioscience.com LEXX|PULM: PEG Multiple|Growth-Adjusted P/E Ratio PTHL|Price/Earnings to Growth Ratio Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Company Value to Earnings Growth Ratio|PEG Multiple IBO|Growth-Adjusted Market Cap to Net Income TNF Pharmaceuticals, Inc.|PEG Multiple YCBD (cbdMD, Inc.)|PRFX (PainReform Corp) - Market Cap to Earnings and Growth Ratio|CYTO: Price/Earnings to Growth Multiple|LIPO - PEG Multiple|OptiNose, Inc. (OPTN) - Price/Earnings to Growth Ratio|PIRS - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Procaps|Price/Earnings to Growth Multiple Petros (PTPI)|Price/Earnings to Growth Ratio Qilian International Corp (QLI)|PEG Multiple acelyrin.com (SLRN)|PEG Multiple TFFP (TFF Pharmaceuticals)